1. Home
  2. HMY vs MEDP Comparison

HMY vs MEDP Comparison

Compare HMY & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Gold Mining Company Limited

HMY

Harmony Gold Mining Company Limited

HOLD

Current Price

$15.71

Market Cap

12.7B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$417.53

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMY
MEDP
Founded
1950
1992
Country
South Africa
United States
Employees
34350
N/A
Industry
Precious Metals
Biotechnology: Commercial Physical & Biological Resarch
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
11.7B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
HMY
MEDP
Price
$15.71
$417.53
Analyst Decision
Buy
Hold
Analyst Count
2
12
Target Price
$16.00
$473.17
AVG Volume (30 Days)
4.8M
451.2K
Earning Date
02-04-2016
04-22-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
20.98
EPS
N/A
4.28
Revenue
N/A
N/A
Revenue This Year
$37.43
$13.19
Revenue Next Year
$27.44
$7.75
P/E Ratio
$15.60
$96.40
Revenue Growth
N/A
N/A
52 Week Low
$13.03
$284.10
52 Week High
$26.04
$628.92

Technical Indicators

Market Signals
Indicator
HMY
MEDP
Relative Strength Index (RSI) 43.54 36.68
Support Level $14.89 $382.68
Resistance Level $16.21 $485.13
Average True Range (ATR) 0.56 17.73
MACD -0.14 -11.40
Stochastic Oscillator 16.01 28.40

Price Performance

Historical Comparison
HMY
MEDP

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: